System suitability

LCGC North America

Volumn 22, Issue 5, 2004, Pages 430-435

  Dolan, John W ^a,b,c  

^a BASi Northwest Laboratory   (United States)

^b LC RESOURCES   (United States)

^c LCGC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749529077     PISSN: 15275949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. USP 27/NF 22, United States Pharmacopoeial Convention, Rockville, Maryland, p. 2281 (2003).
2. International Conference on Harmonization, "Guidance for Industry: Q2B Validation of Analytical Procedures: Methodology," (www.fda.gov/cedr/ guidance/index.htm), p. 10 (1996).
3. U.S. FDA, "Guidance for Industry: Bioanalytical Method Validation," (www.fda.gov/cedr/guidance/index.htm), p. 14 (2001).
4. USP 27, p. 1324 (2003).